Leadership & Pay ·
On July 19, 2026, Lisa Bollinger, MD, resigned as Chief Medical Officer of Polaryx Therapeutics, Inc., effective…
PLYXPolaryx Therapeutics, Inc.
On July 19, 2026, Lisa Bollinger, MD, resigned as Chief Medical Officer of Polaryx Therapeutics, Inc., effective immediately. The company stated that the departure is not expected to impact clinical timelines, regulatory plans, or development strategies. An active search for a successor has begun, with existing leadership assuming her responsibilities in the interim. Polaryx Therapeutics is a biotechnology company focused on drug development.